Published Data Support Scientific Basis for Ganaxolone Use in PCDH19 Female Epilepsy
July 6, 2015Marinus Pharmaceuticals announced that Dr. Jozef Gecz, Professor at the University of Adelaide, published data in the June issue of Human Molecular Genetics, supporting the role for neurosteroids in the pathophysiology of PCDH19 female epilepsy.
More »
Neothetics Initiates Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 for Body Contouring
June 30, 2015Neothetics initiates a supplemental safety study evaluating the first non-invasive injectable drug candidate for fat reduction in non-obese subjects. The company expects to submit to the FDA as part of NDA package and anticipates filing in the second half
More »
Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area
June 29, 2015Veracyte has been included on the Bay Area News Group's prestigious Top Workplaces list for the second year in a row. The news group selects Top Workplace winners based on an annual survey of Bay Area-company employees.
More »